Livforsakringsbolaget Skandia Omsesidigt Buys 527 Shares of Colgate-Palmolive (NYSE:CL)

Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Colgate-Palmolive (NYSE:CL) by 37.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,946 shares of the company’s stock after acquiring an additional 527 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Colgate-Palmolive were worth $155,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Moneta Group Investment Advisors LLC increased its stake in Colgate-Palmolive by 90,253.2% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after buying an additional 15,956,771 shares during the last quarter. Norges Bank acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $644,715,000. Renaissance Technologies LLC increased its stake in Colgate-Palmolive by 151.6% in the 1st quarter. Renaissance Technologies LLC now owns 5,688,786 shares of the company’s stock valued at $431,381,000 after buying an additional 3,427,400 shares during the last quarter. Morgan Stanley increased its stake in Colgate-Palmolive by 41.7% in the 4th quarter. Morgan Stanley now owns 11,370,549 shares of the company’s stock valued at $895,886,000 after buying an additional 3,345,297 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its stake in Colgate-Palmolive by 1,915.2% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,793,287 shares of the company’s stock valued at $135,985,000 after buying an additional 1,704,300 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock worth $19,505,099 over the last three months. Company insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Stifel Nicolaus lifted their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, January 29th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $86.70 on Friday. The company has a market cap of $71.27 billion, a P/E ratio of 31.19, a P/E/G ratio of 3.26 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37. The firm has a 50-day moving average of $87.02 and a 200-day moving average of $80.67.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.77 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is currently 69.06%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.